Literature DB >> 26917072

Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS).

Erick D Bothun1, Michael J Lynn2, Stephen P Christiansen3, Dan E Neely4, Deborah K Vanderveen5, Stacey J Kruger6, Scott R Lambert7.   

Abstract

PURPOSE: To evaluate sensorimotor outcomes among children in the Infant Aphakia Treatment Study (IATS).
METHODS: Secondary outcome analysis was performed in this randomized, multicenter, clinical trial comparing treatment of unilateral aphakia with a primary intraocular lens (IOL) or contact lens (CL) correction. The alignment characteristics and sensory status of children through age 5 years were evaluated.
RESULTS: In the IATS study, 91 of 112 children (81%) developed strabismus through age 5 years. Of 34 infants who were orthotropic at near 12 months after cataract surgery, at age 5 years 14 (41%) were orthotropic at distance, and 15 (44%) were orthotropic at near at age 5 years without strabismus surgery. Eight of 56 children (14%) in the CL group and 13 of 56 (23%) in the IOL group were orthotropic at distance (P = 0.33) at 5 years of age and had no history of strabismus surgery. Thirteen of 48 (27%) who underwent cataract surgery prior to 49 days of age compared to 8 of 64 (13%) who had surgery after 49 days were orthotropic (P = 0.085). Median visual acuity in the operative eye was 0.4 logMAR (20/50) for children with orthotropia or microtropia (<10(Δ)) versus 1.10 logMAR (20/252) for strabismus ≥10(Δ) (P = 0.0001). Stereopsis was detected in 12 of 21 children (57%) with orthotropia versus 16 of 89 (18%) children with strabismus (P = 0.0006).
CONCLUSIONS: IOL placement does not reduce the development of strabismus after monocular congenital cataract surgery. Improved ocular alignment by age 5 years correlated strongly with improved visual acuity and stereopsis.
Copyright © 2016 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26917072      PMCID: PMC4869943          DOI: 10.1016/j.jaapos.2015.11.002

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  22 in total

1.  Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years.

Authors:  Scott R Lambert; Michael J Lynn; E Eugenie Hartmann; Lindreth DuBois; Carolyn Drews-Botsch; Sharon F Freedman; David A Plager; Edward G Buckley; M Edward Wilson
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

2.  Visual results after primary intraocular lens implantation or contact lens correction for aphakia in the first year of age.

Authors:  Rudolf Autrata; Jaroslav Rehurek; Kristina Vodicková
Journal:  Ophthalmologica       Date:  2005 Mar-Apr       Impact factor: 3.250

3.  Strabismus in pediatric lens disorders.

Authors:  Nomiki Spanou; Lampros Alexopoulos; Georgia Manta; Despina Tsamadou; Hristos Drakos; Petros Paikos
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2010-06-23       Impact factor: 1.402

4.  One-year strabismus outcomes in the Infant Aphakia Treatment Study.

Authors:  Erick D Bothun; Julia Cleveland; Michael J Lynn; Stephen P Christiansen; Deborah K Vanderveen; Dan E Neely; Stacey J Kruger; Scott R Lambert
Journal:  Ophthalmology       Date:  2013-02-16       Impact factor: 12.079

5.  Strabismus in pediatric pseudophakia.

Authors:  Oren L Weisberg; Derek T Sprunger; David A Plager; Daniel E Neely; Naval Sondhi
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

6.  The critical period for susceptibility of human stereopsis.

Authors:  Sherry L Fawcett; Yi-Zhong Wang; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

7.  Adherence to occlusion therapy in the first six months of follow-up and visual acuity among participants in the Infant Aphakia Treatment Study (IATS).

Authors:  Carolyn D Drews-Botsch; Marianne Celano; Stacey Kruger; E Eugenie Hartmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

8.  Outcome after very early treatment of dense congenital unilateral cataract.

Authors:  E E Birch; W H Swanson; D R Stager; M Woody; M Everett
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-12       Impact factor: 4.799

9.  The infant aphakia treatment study: design and clinical measures at enrollment.

Authors:  Scott R Lambert; Edward G Buckley; Carolyn Drews-Botsch; Lindreth DuBois; Eugenie Hartmann; Michael J Lynn; David A Plager; M Edward Wilson
Journal:  Arch Ophthalmol       Date:  2010-01

10.  Unilateral pseudophakia in children under 4 years.

Authors:  S Awner; E G Buckley; J M DeVaro; J H Seaber
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1996 Jul-Aug       Impact factor: 1.402

View more
  4 in total

1.  Global Practice Patterns in the Management of Infantile Cataracts.

Authors:  Euna B Koo; Deborah K VanderVeen; Scott R Lambert
Journal:  Eye Contact Lens       Date:  2018-11       Impact factor: 2.018

2.  Factors associated with stereopsis and a good visual acuity outcome among children in the Infant Aphakia Treatment Study.

Authors:  S R Lambert; L DuBois; G Cotsonis; E E Hartmann; C Drews-Botsch
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

3.  Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years.

Authors:  Erick D Bothun; Michael J Lynn; Stephen P Christiansen; Stacey J Kruger; Deborah K Vanderveen; Dan E Neely; Scott R Lambert
Journal:  J AAPOS       Date:  2016-11-02       Impact factor: 1.220

4.  Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study.

Authors:  Deborah K VanderVeen; Carolyn D Drews-Botsch; Azhar Nizam; Erick D Bothun; Lorri B Wilson; M Edward Wilson; Scott R Lambert
Journal:  J Cataract Refract Surg       Date:  2021-02-01       Impact factor: 3.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.